FDA Approves BICILLIN C-R 900/300 — Pfizer Laboratories Div Pfizer Inc

Pfizer has received FDA approval for BICILLIN C-R 900/300, the combined dosage form of Penicillin G Benzathine and Penicillin G Procaine, reviving the product status in its historical portfolio. This regulatory milestone is expected to address critical gaps in penicillin G inventory and diversify Pfizer's antibiotic offerings to minimize pressure on the beleaguered penicillin generics market.